PetVivo Holdings, Inc. (PETV)
Largest Insider Buys in Sector
PETV Stock Price History Chart
PETV Stock Performance
About PetVivo Holdings, Inc.
PetVivo Holdings, Inc., a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The company's pipeline products also include 17 therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. was founded in …
Insider Activity of PetVivo Holdings, Inc.
Over the last 12 months, insiders at PetVivo Holdings, Inc. have bought $90,000 and sold $0 worth of PetVivo Holdings, Inc. stock.
On average, over the past 5 years, insiders at PetVivo Holdings, Inc. have bought $100,748 and sold $28,485 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Lai John (CEO and President) — $90,000.
The last purchase of 150,000 shares for transaction amount of $90,000 was made by Lai John (CEO and President) on 2024‑04‑15.
List of Insider Buy and Sell Transactions, PetVivo Holdings, Inc.
| 2024-04-15 | CEO and President | 150,000 0.8726% | $0.60 | $90,000 | -10.41% | |||
| 2023-08-21 | director | 22,224 0.206% | $2.29 | $51,003 | -53.49% | |||
| 2023-03-15 | director | 3,350 0.0331% | $3.02 | $10,132 | -36.47% | |||
| 2023-03-13 | director | 2,000 0.0203% | $3.10 | $6,200 | -36.30% | |||
| 2023-03-01 | director | 500 0.005% | $2.94 | $1,470 | -32.76% | |||
| 2023-02-28 | director | 501 0.0051% | $3.12 | $1,563 | -35.95% | |||
| 2023-02-27 | director | 1,399 0.0129% | $2.97 | $4,149 | -38.56% | |||
| 2023-02-24 | director | 2,600 0.0255% | $2.98 | $7,736 | -34.88% | |||
| 2023-02-21 | director | 3,300 0.0326% | $3.00 | $9,885 | -34.33% | |||
| 2023-02-16 | director | 103 0.001% | $2.99 | $308 | -32.88% | |||
| 2023-02-15 | director | 8,400 0.0761% | $2.65 | $22,291 | -31.72% | |||
| 2023-02-14 | director | 7,899 0.0739% | $2.56 | $20,236 | -26.94% | |||
| 2022-11-22 | CEO and President | 1,000 0.0099% | $2.50 | $2,500 | -14.00% | |||
| 2022-11-21 | CEO and President | 1,000 0.0103% | $2.55 | $2,550 | -11.89% | |||
| 2022-11-21 | director | 860 0.0092% | $2.65 | $2,279 | -11.89% | |||
| 2022-11-18 | CEO and President | 1,110 0.011% | $2.60 | $2,885 | -17.31% | |||
| 2022-11-18 | director | 1,640 0.016% | $2.56 | $4,202 | -17.31% | |||
| 2022-11-17 | CEO and President | 1,856 0.0179% | $2.47 | $4,584 | -15.35% | |||
| 2022-11-16 | CEO and President | 2,034 0.0192% | $2.44 | $4,966 | -15.63% | |||
| 2022-11-15 | CEO and President | 3,000 0.0295% | $2.36 | $7,070 | -8.82% |
Insider Historical Profitability
| Lai John | CEO and President | 1288592 6.1782% | $0.58 | 10 | 0 | <0.0001% |
| Dolan John F. | CFO | 363393390 1742.2923% | $0.58 | 1 | 0 | |
| Rudelius Robert James | director | 208611 1.0002% | $0.58 | 2 | 0 | <0.0001% |
| Martin James Rudolph | director | 146041 0.7002% | $0.58 | 27 | 0 | <0.0001% |
| Martin James Joseph | director | 67384 0.3231% | $0.58 | 1 | 0 |